UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033422
Receipt number R000038109
Scientific Title Elucidation of individual difference factors in the pharmacokinetics and clinical effects of anticoagulants edoxaban and enoxasaparin
Date of disclosure of the study information 2018/07/30
Last modified on 2021/03/19 23:07:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Elucidation of individual difference factors in the pharmacokinetics and clinical effects of anticoagulants edoxaban and enoxasaparin

Acronym

Elucidation of individual difference factors in the pharmacokinetics and clinical effects of anticoagulants edoxaban and enoxasaparin

Scientific Title

Elucidation of individual difference factors in the pharmacokinetics and clinical effects of anticoagulants edoxaban and enoxasaparin

Scientific Title:Acronym

Elucidation of individual difference factors in the pharmacokinetics and clinical effects of anticoagulants edoxaban and enoxasaparin

Region

Japan


Condition

Condition

Artificial knee replacement surgery

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Elucidation of individual differences in therapeutic effects and side effects of edoxaban and enoxaparin

Basic objectives2

PK,PD

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Efficacy (presence of thrombus by CT imaging)

Key secondary outcomes

Safety (with subcutaneous bleeding)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation

YES

Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Edoxaban

Interventions/Control_2

Enoxaparin

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

undergoing knee replacement

Key exclusion criteria

Patients with a history of DVT and PTE.
Patients with diseases with abnormal coagulability.
Patient who can not obtain written informed consent.
Patients contraindicated with edoxaban or enoxaparin.
Patients taking warfarin.Other patients judged inappropriate by the attending physician.



Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kaneko,Hironori

Organization

Kitasato University, Kitasato Institute Hospital

Division name

Orthopedics

Zip code


Address

5-9-1 shirokane minato-ku tokyo

TEL

03-3444-6161

Email

hiroka@insti.kitasato-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name shibata,soichi

Organization

Kitasato University, Kitasato Institute Hospital

Division name

Pharmacy

Zip code


Address

5-9-1 shirkane minato-ku tokyo

TEL

03-3444-6161

Homepage URL


Email

shibasoh@insti.kitasato-u.ac.jp


Sponsor or person

Institute

Kitasato University

Institute

Department

Personal name



Funding Source

Organization

Kitasato University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北里大学北里研究所病院


Other administrative information

Date of disclosure of the study information

2018 Year 07 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2015 Year 04 Month 24 Day

Date of IRB

2015 Year 04 Month 24 Day

Anticipated trial start date

2015 Year 06 Month 04 Day

Last follow-up date

2018 Year 08 Month 07 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 07 Month 17 Day

Last modified on

2021 Year 03 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038109


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name